The alternatives
Direct Meds scores 82/100 (grade B−, ranked #29) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to Direct Meds's 82, and our Direct Meds vs CoreAge Rx comparison sets the two out factor by factor.
One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.
Renlo Health scores 85/100 to Direct Meds's 82; our Renlo Health review in full has the pricing conditions and the caveats in detail.
Rock-bottom pricing on both molecules plus an oral route, nationwide — with the trade-off of no LegitScript listing.
Alan Meds scores 84/100 to Direct Meds's 82; the full Alan Meds review has the pricing conditions and the caveats in detail.
Six programs across four terms on one public page, four dispensing pharmacies named with addresses, and a no-intro-rate commitment the arithmetic actually supports.
No BS RX scores 85/100 to Direct Meds's 82; our full write-up on No BS RX has the pricing conditions and the caveats in detail.
A flat-fee compounded pioneer — simple model, but priced at the higher end now.
Henry Meds scores 84/100 to Direct Meds's 82; the full Henry Meds review has the pricing conditions and the caveats in detail.
Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.
Telos Rx scores 85/100 to Direct Meds's 82; our Telos Rx review in full has the pricing conditions and the caveats in detail.
Cheap semaglutide and nationwide coverage, with a tirzepatide markup and no LegitScript listing.
Live Vital scores 83/100 to Direct Meds's 82; our Live Vital review in full has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.